Boom in weight-loss drugs could lead to drop in beer sales, Heineken warns British pubs
Heineken has warned British pubs that the rising popularity of weight-loss drugs like Ozempic and Wegovy may lead to a decline in beer and cider sales. The brewer suggests that these drugs reduce the desire for alcohol, prompting them to advise pubs to diversify their offerings.
Why it matters
This reflects the broader economic impact of the GLP-1 drug boom on the hospitality and beverage industries.
Heineken offered advice to pubs, including promoting half pints, low- and zero-alcohol options and pairing drinks with small plates of food./iStockphoto Heineken offered advice to pubs, including promoting half pints, low- and zero-alcohol options and pairing drinks with small plates of food./iStockphoto Hospitality industry Boom in weight-loss drugs could lead to drop in beer sales, Heineken warns British pubs World’s second largest brewer says use of drugs such as Wegovy can reduce desire to drink alcohol
Prefer the Guardian on Google Heineken has warned British bars and pubs that the boom in popularity of weight-loss drugs could lead to a fall in sales of beer and cider.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in